Previous 10 | Next 10 |
NEW YORK , Aug. 7, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020 , and ho...
Since the pandemic struck, temperature screening has been used to find those that are infected with COVID-19, and this has made your body temperature to be no longer private information. Your body temperature is soon becoming like a pass for you to access buildings. Most business premises are ...
DarioHealth Corp. is an digital therapeutics (“DTx”) pioneer supplying remote health condition monitoring technology to caregivers and their patients The company recently reported a successful private placement funding transaction that provides Dario with $28.6 million in ag...
Gainers : IMAC Holdings (NASDAQ: IMAC ) +59% . More news on: IMAC Holdings, Inc., MYOS RENS Technology Inc., Marathon Patent Group, Inc., Stocks on the move, Read more ...
The presence of SARS-COV-2 in cats and dogs has caught the attention of scientists. Many scientists have been researching whether the pets can transmit other pathogens, such as drug-resistant bacteria, to human beings. Effects of multidrug-resistant organisms crossing from pets to humans ...
Gainers: Sonnet BioTherapeutics (NASDAQ: SONN ) +97% . More news on: Sonnet BioTherapeutics Holdings, Inc., Zion Oil & Gas, Inc., Fluidigm Corporation, Stocks on the move, , Read more ...
NEW YORK , July 31, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including healthcare funds and institutions from the U.S. and Israel ....
Drug resistance is a serious medical concern and poses a severe health threat in the medical fraternity. In this regard, antimicrobial resistance is one of the worst nightmares that most patients suffering from various infections continue to grapple with across the world. Generally, antimicr...
DarioHealth Corp. is a digital therapeutics innovator that supplies remote monitoring technology to caregivers and their patients The company’s Remote Patient Monitoring (“RPM”) technology reports patient data to care providers in the clinical setting and if necessary...
The COVID-19 pandemic has created economic disruptions as a result of the shutdown orders given by the authorities. This has led many companies to start scaling back on their intellectual property (“IP”) expenses. However, the crisis has also created an opportunity for others to ...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the first quarter 2024, the period ended March 31, 2024. According to the announcement, the company will release the report on May 15, 2024, before the market opens. In addi...
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the globa...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...